Literature DB >> 11988022

Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling.

C Lilliehook1, S Chan, E K Choi, N F Zaidi, W Wasco, M P Mattson, J D Buxbaum.   

Abstract

Calsenilin (also called DREAM and KChIP3), a member of the neuronal calcium sensor family, was isolated in a yeast two-hybrid screen using an apoptotic domain of presenilin 2 as bait. Calsenilin is a cytoplasmic protein, but interacts with the COOH-termini of both presenilin 1 and presenilin 2 at the endoplasmic reticulum and the Golgi apparatus. In this study, we have investigated calsenilin's effect on apoptosis. In stable neuroglioma cell lines, we observed that calsenilin enhances apoptosis in response to serum withdrawal or thapsigargin. Consistent with these observations, caspase and apparently calpain activities were increased during apoptosis in calsenilin-overexpressing cells. Moreover, using calcium imaging we were able to show that cells treated with thapsigargin released more calcium from intracellular stores when calsenilin was overexpressed. Taken together, these data suggest that calsenilin causes cells to be more susceptible to apoptotic triggers, possibly by altering calcium dynamics. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988022     DOI: 10.1006/mcne.2001.1096

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  22 in total

1.  Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

Authors:  Alessio Crestini; Paola Piscopo; Mariavittoria Iazeolla; Diego Albani; Roberto Rivabene; Gianluigi Forloni; Annamaria Confaloni
Journal:  J Mol Neurosci       Date:  2010-10-28       Impact factor: 3.444

2.  Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.

Authors:  Michael A Grillo; Stephanie L Grillo; Bryan C Gerdes; Jacob G Kraus; Peter Koulen
Journal:  Mol Neurobiol       Date:  2018-05-05       Impact factor: 5.590

Review 3.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 4.  Downstream Regulatory Element Antagonist Modulator (DREAM), a target for anti-thrombotic agents.

Authors:  Jaehyung Cho
Journal:  Pharmacol Res       Date:  2017-01-05       Impact factor: 7.658

5.  DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Pilar Larrodé; Ana Cristina Calvo; Laura Moreno-Martínez; Miriam de la Torre; Leticia Moreno-García; Nora Molina; Tomás Castiella; Cristina Iñiguez; Luis Fernando Pascual; Francisco Javier Miana Mena; Pilar Zaragoza; Santiago Ramón Y Cajal; Rosario Osta
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

6.  Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.

Authors:  Carolin Seifert; Stephan Storch; Robert Bähring
Journal:  J Biol Chem       Date:  2020-07-07       Impact factor: 5.157

7.  Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression.

Authors:  Magali Savignac; Belen Pintado; Alfonso Gutierrez-Adan; Malgorzata Palczewska; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

8.  KChIP3 coupled to Ca2+ oscillations exerts a tonic brake on baseline mucin release in the colon.

Authors:  Gerard Cantero-Recasens; Cristian M Butnaru; Miguel A Valverde; José R Naranjo; Nathalie Brouwers; Vivek Malhotra
Journal:  Elife       Date:  2018-10-01       Impact factor: 8.140

9.  The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I.

Authors:  Theodore A Craig; Pradeep L Ramachandran; H Robert Bergen; Jewel L Podratz; Anthony J Windebank; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2013-03-21       Impact factor: 3.575

10.  DREAM (downstream regulatory element antagonist modulator) contributes to synaptic depression and contextual fear memory.

Authors:  Long-Jun Wu; Britt Mellström; Hansen Wang; Ming Ren; Sofia Domingo; Susan S Kim; Xiang-Yao Li; Tao Chen; Jose R Naranjo; Min Zhuo
Journal:  Mol Brain       Date:  2010-01-21       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.